Piper Sandler lowered the firm’s price target on Guardant Health to $35 from $50 and keeps a Neutral rating on the shares. The analyst updated estimates post the earnings report.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on GH:
- Guardant Health price target lowered to $66 from $73 at Morgan Stanley
- Guardant Health price target lowered to $50 from $60 at BTIG
- Guardant Health price target lowered to $60 from $65 at Canaccord
- Guardant Health price target lowered to $53 from $70 at Cowen
- Guardant Health price target lowered to $65 from $75 at JPMorgan
